Joel Latham - CEO, Incannex Healthcare - Combination Therapies For Challenging Chronic Conditions

Joel Latham is the Chief Executive Officer, President, and Director of Incannex Healthcare Inc. ( https://incannex.com/ ) a science-led combination medicines company leading the way in developing cannabinoid-based medicines and psychedelic-based regimens for people living with challenging chronic conditions.

Incannex Healthcare’s science-driven programs are exploring the therapeutic potential of oral synthetic cannabinoid and psilocybin drug candidates in sleep apnea, anxiety, and inflammatory diseases. 

Joel brings more than 20 years of senior management and operations experience in both public and private sectors, and under Joel’s leadership, Incannex has advanced, and prioritized multiple therapeutic candidates into clinical-stage development. 

Previously, Joel was the CEO and Managing Director of Incannex Australia, where he played a key role in the company’s growth and its successful transition to Nasdaq. 

Joel has also held senior leadership roles in corporate strategy and global market development at Mars Foods, Tabcorp, and Philip Morris International.

#JoelLatham #IncannexHealthcare #CombinationMedicines #CannabinoidBasedMedicines #PsychedelicBasedRegimens #ObstructiveSleepApnea #RheumatoidArthritis #GeneralizedAnxietyDisorder #Acetazolamide #Dronabinol #Cannabidiol #Hydroxychloroquine #Psilocybin #STEM #Innovation #Science #Technology #Research #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #Podcasting #ViralPodcast